Founded in 2005, Newland Pharmaceutical Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company is known for its significant contributions to the pharmaceutical industry with products such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, and tadalafil. Newland Pharmaceutical is recognized as a National Hi-tech Enterprise and has multiple certifications including ISO 9001, ISO 14001, and OHSAS 18001.